The Full Spectrum of News.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Social Media
NATO
Donald Trump
Education
Heatwaves
European Union
Soccer
World Cup
Natural Disasters
Trade
Senate
Published • loading... • Updated

New dawn for NeuroScientific with stem cell acquisition

Summary by Sydney Morning Herald
NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company Isopogen.

5 Articles

All
Left
2
Center
Right
1
Sydney Morning HeraldSydney Morning Herald
+3 Reposted by 3 other sources
Lean Left

New dawn for NeuroScientific with stem cell acquisition

NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company Isopogen.

·Sydney, Australia
Read Full Article
Business NewsBusiness News

NeuroScientific completes Isopogen acquisition

NeuroScientific has completed its acquisition of Perth pharmaceuticals company Isopogen WA, which controls the StemSmart technology patent, in a bid to boost its stem cell offerings.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Left
67% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sydney Morning Herald broke the news in Sydney, Australia on Friday, June 27, 2025.
Sources are mostly out of (0)

Similar News Topics

Business icon

Business

Western Australia icon

Western Australia

Australia Economy icon

Australia Economy

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal